Various types of SGLT-2 inhibitors exhibit different adverse events, particularly hypoglycemia, genitourinary infection, ketoacidosis, acute kidney injury (AKI), fractures or amputations, and other adverse events. The gene discussed is SLC5A2; the disease is acute kidney injury.